This announcement is made pursuant to rule 17.06A of the Rules Governing the Listing of Securities of The Stock Exchange of Hong Kong Limited.
The board of directors (the 'Board') of Lee's Pharmaceutical Holdings Limited (the 'Company', together with its subsidiaries, the 'Group'), announces that on 23 October 2020, the Company has granted share options (the 'Options') to subscribe for a total of 2,000,000 ordinary shares of the Company (the 'Shares') under the share option scheme adopted on 10 May 2012 (the 'Share Option Scheme').
Among the Options granted above, none of the grantees of the Options is a director, chief executive or substantial shareholder (as defined under the Listing Rules) of the Company, or any of their respective associates (as defined under the Listing Rules).
Contact:
Tel: (+852) 2314-1708
Email: info@leespharm.com
(C) 2020 Electronic News Publishing, source ENP Newswire